| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.075 | 0.2 |